Tvardi Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.71

+0.10 (+6.21%)

As of Sep 22, 5:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 79%

Hold 2 14%

Sell 1 7%

Price Target

Analyst Price Target +2,126.3% upside

Low Target $23.38

Average Target $38.07

High Target $43.34

Current Price $1.71

Current
$1.71

Target
$38.07

$23.38 $38.07 avg $43.34

Scenario Analysis

Bear Case

$23.38

1,267.3%

Low target

Base Case

$38.07

+2,126.3%

Avg target

Bull Case

$43.34

+2,434.5%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$43.65

-96.1% from high

52-Week Low

$1.50

+14.0% from low

Target vs 52W High

$38.07

-12.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%